First published as a weekly print newsletter in March 1972, Scrip included articles on side-effects, regulatory changes and mergers and acquisitions.

[1][2][3] Scrip has now developed into an online global pharma news and analysis service.

In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus.

Scrip is read by managers and executives working across all disciplines in pharmaceutical and biotech companies worldwide.

The journalists are based throughout the world in Washington, D.C., Tokyo, India, and London to ensure a global emphasis to the latest news stories.